PlainRecalls

Becton Dickinson & Co.

Compiled from official public sources by the editorial team.

185 recalls on record · Latest: May 6, 2026

Becton Dickinson & Co. Recall Insight

Becton Dickinson & Co. appears on 185 federal recall records indexed by PlainRecalls, out of 101,704 total recalls tracked across the FDA, CPSC, and NHTSA. That represents approximately 0.182% of the federal archive, a data point that is only interpretable alongside production volume, product mix, and decades of operation, because a high recall count alone does not establish fault. Large, diversified firms that sell tens of millions of units across many categories will mechanically accumulate more recall records than small manufacturers, even when their defect rates per unit shipped are comparable or lower. The most recent action on this firm is dated May 6, 2026, which is the anchor point for assessing whether enforcement is currently active or historical.

On this page of 50 entries, severity tagging shows 0 critical, 50 moderate, and 0 lower-severity recalls. Affected-unit counts are disclosed on 50 of 50 entries, unit-count disclosure is more common on CPSC and NHTSA actions and less common on FDA drug/device recalls, where lot numbers and distribution scope substitute for absolute totals. The records on this page span 1 distinct product categories, with issuing agencies dominated by FDA Devices (50). The date window on this page runs from Aug 28, 2019 to Feb 14, 2024.

Manufacturer-level browsing is useful when monitoring a single firm for patterns, whether recalls cluster around one product family (suggesting a specific design or supplier issue) or scatter across the firm's entire catalog (which can indicate systemic quality-control problems or deliberate regulator attention). Clicking into each recall reveals the specific hazard, remedy, and distribution scope that together determine whether a consumer is actually at risk. For decisions that depend on being current, deciding whether a product in your home is safe, whether to return a gift, or whether to accept a replacement, always verify the recall number on the issuing agency's site, because federal agencies amend, terminate, and re-scope recalls over time and only the agency's live record reflects the current legal status. This page aggregates what agencies have published publicly and is intended for consumer awareness and research.

FDA Devices Moderate Feb 14, 2024

BD BBL Sensi Disc Ertapenem- 10 ug, used for semi-quantitative in vitro susceptibility testing. Catalog Number 232174 and 232175¿

FDA Devices Moderate Feb 14, 2024

BD BBL Sensi Disc Ciprofloxacin- 5 ug, used for semi-quantitative in vitro susceptibility testing. Catalog Number 231657¿and 231658¿

FDA Devices Moderate Feb 14, 2024

BD BBL Sensi Disc Aztreonam - 30 ug¿, used for semi-quantitative in vitro susceptibility testing. Catalog Numbers 231640¿and 231641.

FDA Devices Moderate Feb 14, 2024

BD BBL Sensi Disc Levofloxacin- 5 ug, used for semi-quantitative in vitro susceptibility testing. Catalog Number 231705 and 231706¿

FDA Devices Moderate Feb 14, 2024

BD BBL Sensi Disc Augmentin - 3¿g, Catalog Number 291270¿used for semi-quantitative in vitro susceptibility testing.

FDA Devices Moderate Feb 14, 2024

BD BBL Sensi Disc Sulfamethoxazole with Trimethoprim 23.75/1.25 ug, used for semi-quantitative in vitro susceptibility testing. Catalog Number 231536…

FDA Devices Moderate Feb 14, 2024

BD BBL Sensi Disc Ceftazidime- 30 ug, used for semi-quantitative in vitro susceptibility testing. Catalog Number 231632¿and 231633¿

FDA Devices Moderate Feb 14, 2024

BD BBL Sensi Disc Ofloxacin- 5 ug, used for semi-quantitative in vitro susceptibility testing. Catalog Number 231672¿

FDA Devices Moderate Feb 14, 2024

BD BBL Sensi Disc Cefixime - 5 ug¿, used for semi-quantitative in vitro susceptibility testing. Catalog Number 231664¿

FDA Devices Moderate Feb 14, 2024

BD BBL Sensi Disc Ampicillin - 10 ¿g, Catalog No. 230705 and 231264; 2 ¿g, Catalog No. 231263. Used for semi-quantitative in vitro susceptibility tes…

FDA Devices Moderate Feb 14, 2024

BD BBL Sensi Disc Cefuroxime- 30 ug, used for semi-quantitative in vitro susceptibility testing. Catalog Number 231621¿

FDA Devices Moderate Feb 14, 2024

BD BBL Sensi Disc Ceftriaxone- 30 ug, used for semi-quantitative in vitro susceptibility testing. Catalog Number 231634 and 231635¿

FDA Devices Moderate Feb 14, 2024

BD BBL Sensi Disc Doripenem- 15 ug, used for semi-quantitative in vitro susceptibility testing. Catalog Number 232219¿

FDA Devices Moderate Feb 14, 2024

BD BBL Sensi Disc Ampicillin with Sulbactam 10/10 ¿g, Catalog Number 231660. Used for semi-quantitative in vitro susceptibility testing.

FDA Devices Moderate Feb 14, 2024

BD BBL Sensi Disc Clarithromycin- 15 ug, used for semi-quantitative in vitro susceptibility testing. Catalog Number 231678¿

FDA Devices Moderate Oct 18, 2023

BD BACTEC Plus Aerobic/F Culture Vials, Catalog Number 442023

FDA Devices Moderate Jul 12, 2023

BD Synapsys Informatics Solution, Catalog Number 444150

FDA Devices Moderate Jun 14, 2023

BD Veritor System for Rapid Detection of SARS-CoV-2 & Flu A+B, 30 Single Use Test Devices- Intended for the in vitro, simultaneous qualitative detec…

FDA Devices Moderate Apr 26, 2023

BD Kiestra InoqulA+ with BD Kiestra" InoqulA+" and BeA Software version 5.1 and 5.1.1 as part of the Icefall A platform. An in vitro diagnostic medi…

FDA Devices Moderate Dec 21, 2022

BBL Chocolate II Agar- IVD for the isolation and cultivation of Neisseria species. Catalog (Ref) Number: 221267

FDA Devices Moderate Nov 23, 2022

BD Phoenix PMIC/ID-107: The Phoenix PMIC/ID panel is used for the rapid identification and susceptibility of most aerobic and facultative anaerobic …

FDA Devices Moderate May 11, 2022

BD Synapsys Microbiology Informatics Solution, Catalog Number 444150, Software Version 4.10

FDA Devices Moderate Feb 16, 2022

BD Veritor Plus Analyzer - intended to provide rapid test results in near-patient settings. Catalog Number: 256066

FDA Devices Moderate Apr 21, 2021

BioGX SARS-CoV-2 Reagents for BD MAX System-IVD PCR test intended for the qualitative detection of nucleic acid from the SARS-CoV-2 in nasopharyngea…

FDA Devices Moderate Apr 14, 2021

BD BBL Martin-Lewis Agar, 100 Ea - Product Usage: used for the isolation of pathogenic Neisseria from specimens containing mixed flora of bacteria a…

FDA Devices Moderate Apr 14, 2021

BD BBL Martin-Lewis Agar 20 Ea - Product Usage: use for the isolation of pathogenic Neisseria from specimens containing mixed flora of bacteria and f…

FDA Devices Moderate Feb 17, 2021

BioGX SARS-CoV-2 Reagents for BD MAX System Catalog number (REF) 444213. In vitro diagnostic. SARS-CoV-2 Reagents is a real-time RT-PCR test i…

FDA Devices Moderate Jan 6, 2021

BD Phoenix PMIC-107: IVD is intended for the in vitro rapid identification (ID) of gram-positive bacteria from pure culture belonging to the genera …

FDA Devices Moderate Jan 6, 2021

BD Phoenix PMIC/ID-108: IVD is intended for the in vitro rapid identification (ID) of gram-positive bacteria from pure culture belonging to the gene…

FDA Devices Moderate Jan 6, 2021

BD Phoenix PMIC-108: IVD is intended for the in vitro rapid identification (ID) of gram-positive bacteria from pure culture belonging to the genera …

FDA Devices Moderate Jan 6, 2021

BD Phoenix" PMIC-109: IVD is intended for the in vitro rapid identification (ID) of gram-positive bacteria from pure culture belonging to the genera…

FDA Devices Moderate Jan 6, 2021

BD Phoenix PMIC/ID-105: IVD is intended for the in vitro rapid identification (ID) of gram-positive bacteria from pure culture belonging to the gene…

FDA Devices Moderate Jan 6, 2021

BD Phoenix PMIC/ID-109: IVD is intended for the in vitro rapid identification (ID) of gram-positive bacteria from pure culture belonging to the gene…

FDA Devices Moderate Jan 6, 2021

BD Phoenix PMIC/ID-107: IVD is intended for the in vitro rapid identification (ID) of gram-positive bacteria from pure culture belonging to the gene…

FDA Devices Moderate Jan 6, 2021

BD Phoenix PMIC-110: IVD is intended for the in vitro rapid identification (ID) of gram-positive bacteria from pure culture belonging to the genera …

FDA Devices Moderate Aug 12, 2020

BD MAX SARS-CoV-2 Reagents, Cat. No. 445003 (UDI 00382904450038) and 445003-01 (UDI (01)603829044500301) - Product Usage: intended for the qualitativ…

FDA Devices Moderate May 27, 2020

BD BBLTM Gram Crystal Violet 250mL-- IVD Primary stain for Staining Microorganisms, Catalog Number: 212525 - Product Usage: Gram Stain Kits and Reage…

FDA Devices Moderate May 27, 2020

BD BBLTM Gram Crystal Violet 3.8L-- IVD Primary stain for Staining Microorganisms, Catalog Number: 212526 - Product Usage: Gram Stain Kits and Reagen…

FDA Devices Moderate May 27, 2020

BD BBLTM Gram Stain Kit with Stabilized Iodine-- IVD For the differential staining of bacteria, Catalog Number: 212539 - Product Usage: Gram Stain Ki…

FDA Devices Moderate Sep 11, 2019

BD Kiestra InoqulA+ Software Version 20.3. IVD automated specimen processing Catalog Number : 447213

FDA Devices Moderate Sep 11, 2019

BD Kiestra InoqulA Software Version 20.3.IVD automated specimen processing Catalog Number: 447202

FDA Devices Moderate Aug 28, 2019

Kit BD Max Enteric Viral Panel RUO; Catalog # 443715

FDA Devices Moderate Aug 28, 2019

Kit BD Max StaphSR; Catalog # 443418

FDA Devices Moderate Aug 28, 2019

Kit BD Max ExK DNA 1 USA; Catalog # 442817

FDA Devices Moderate Aug 28, 2019

Kit EXT Enteric Bacterial Panel; Catalog # 443812

FDA Devices Moderate Aug 28, 2019

Kit BD Max Check-Points CPO IVD EU; Catalog # 278102

FDA Devices Moderate Aug 28, 2019

Kit BD Max Enteric Viral Panel EU Catalog # 443985

FDA Devices Moderate Aug 28, 2019

Kit BD Max ExK TNA 2; Catalog # 442825

FDA Devices Moderate Aug 28, 2019

Kit BD Max ExK DNA 1 EU LUO; Catalog # 442818

FDA Devices Moderate Aug 28, 2019

Kit BD Max MRSA; Catalog # 442953

Nearby Manufacturers

Other firms with recall activity tracked in the PlainRecalls index.

Compare Becton Dickinson & Co. with Zimmer Biomet, Inc. →

Data Sources

  • Source: FDA + CPSC + NHTSA - federal recall filings naming this firm. Verify with FDA, CPSC, or NHTSA directly.
  • Source: PlainRecalls Manufacturer Index - firm-level aggregation across all three federal recall feeds

Every figure on PlainRecalls is rendered directly from official FDA, CPSC and NHTSA recall records, no number is typed in by an editor. Recalls are aggregated across FDA, CPSC and NHTSA filings that name this firm; the total reflects the federal record, not an independent investigation. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of July 2026.